Caladrius Biosciences

+$0.01 (+0.74%) Today
+$0.01 (+0.74%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLBS and other ETFs, options, and stocks.

About CLBS

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16 and CLBS03.

CEO
David J. Mazzo
Employees
24
Headquarters
Basking Ridge, New Jersey
Founded
1980

CLBS Key Statistics

Market Cap
91.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
403.19K
High Today
$1.38
Low Today
$1.33
Open Price
$1.35
Volume
245.81K
52 Week High
$4.89
52 Week Low
$1.25

CLBS Earnings

-$0.47
-$0.31
-$0.16
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure